Clinical review: a clinical investigation was performed.A temporal relationship exists between hd therapy utilizing the optiflux 160 nre dialyzer and the serious adverse events of itching and hyperglycemia.The cause of the itching was attributed to a hyperglycemic reaction.Per the pdrn, the patient has resumed the use of the optiflux 160nre dialyzer without issue.Based on the information available, the optiflux 160nre dialyzer can be disassociated from the events, as there is no allegation or objective evidence indicating an optiflux 160 nre dialyzer product deficiency or malfunction caused or contributed to the serious adverse events.The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
|
Plant investigation: the reported complaint was not confirmed as the complaint device was not returned for manufacturer evaluation.As no lot number was provided for this complaint, a search was performed to obtain all lot numbers, performed to obtain all lot numbers with the reported catalog number delivered to the customer in the three months prior to the complaint occurrence date.There were no lots delivered in that time period.The search was then extended to find the last delivered lot with the reported catalog number.A review of the production record was performed.There was no indication of product non-acceptance or deviation in the manufacturing process potentially related to the complaint.This includes non-conformances, rework, labeling, process controls and any other occurrence in production.The reported lot number passed pyrogen testing, was within sterilization dosage parameters and passed all release criteria.A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device.Therefore, the complaint is not confirmed.
|